Cytotoxic drugs and immunotherapy Flashcards
what are the side effects associated with cyclophosphamide and ifosfamide
Haemorrhagic cystitis due to urinary metabolite acreolein which is prevented by increasing fluid intake for 24-48 hrs after IV injection
mesna is given routinely with Ifosfamide and with high doses of cyclophosphamide e.g over 2g or when pt is considered high risk to prevent haemorrhagic cystitis as well
Cyclophosphamide, Ifosdamide, Melphan and Crmustine are all examples of which type of agents
alkylating
For ifosfamide what are the monitoring requirements
GFR and tubular refill rate need to be checked before each cycle
need to endure satisfactory electrolyte balance and renal function before wach course
what is melphalan and what is it used for
derivative of nitrogen mustard and phelyalanine making it slightly more selective towards rapidly dividing cells
multiple myeloma , carcinoma and advcaned breast cancer
what are the side effects of melphalan
monitor blood count before and throughout
what are the side effects associated with Carmustine
Pulmonary toxicity - dose related, cumulative and may be delayed
Hepatoxicity- high IV doses, may be delayed up to 60 days aftre admin, usually reversible
what is carmustine and what is it used for
a small lipohilic molecule used in CNS tumours and haematological malignancy -myeloma and lymphoma.
hodgskins, leukaemia and brain tumour, intralesional implants for treatment of recurrent glioblastoma and malignant glioma
what type of drugs are doxorubicin, epirubicin and daunorubicin
antibiotics anthracyclines
what are the side effects assocaiated with doxorubicin
Cardiomyopathy - higher cumulative doses. limit 450ng/m2
liposomal formulations- reduce cardiotoxicty and local necrosis, however can cause infusion reactions
liposomal can cause hand-foot syndrome
elevelates bilirubin coc
what are the monitoring requirements for doxorubicin
befrore treatment echocardiogram
cardiac monitoring
what are the s/e of epirubicin
c aution with cumulative doses exceeding 900mg/m2 dur to risk of congestive heart failure increased
what are the side effects of daunorubicin
cardiotoxicity is cumulative and may be reverible
moa of alkalting agents
non specific so act on all rapidly dividing cells
transfer alkyl group to purine bases on DNA - adenine and guanine resulting in cross linking = apoptosis
what are the general side effects of alkylating agents
anaemia, pancytopenia, amenorrhoea, mucosal damage, alopecia, increased risk of malignancy
which enzyme are cyclophosphamide and ifosfamide metabolized by
cytochrome P450 enzyme
what is chlorambucil
an alkylating agent that is a well absorbed nitrogen mustard derivative
name the alkylating agents
melphalan Cyclophosphamide Ifosfamide Chlorambucil Camustine
name the anti-tumour antibiotics
anthracyclines- doxorubicin , daunorubicin, epirubicin, idarubicin
mitomycin
dactinomycin
moa of dactinomycin
binds to DNA and inhibits the synthesis of RNA and proteins
s/e of mitomycin
myelosuppression esp thrombocytopenia
What is the moa of anthracyclines
act on signal transduction
generate free radicals
target topoisomerase II leading to strand breaks and cell death
what the s/e of anthracyclines
myelosuppression
mucosistis
alopecia
cardiotoxicity- due to generate of free radicals in the heart ECHO required before treatment with anthracyclinesand during treatment. Lifetime dose can not be exceeded
what is the moa of plant alkaloids amd the two types
tubulin interactive agents that act by binding to tubulin (protein that forms cellular microtubules used for cell division- specifically metaphase)
Vinka alkaloids
Taxanes
name the vinka alkaloids
vinblastine, vincristine, vinorelbine
name the taxanes
Docetaxel, paciltaxel, cabazitxel
s/e of vinka alkaloids
neurotoxicity, extravasation, myelosuppression
must not be given intrathecally- cn cause severe neurotoxicty that is fatal
s/e of taxanes
Hypersensitivity reactions so may require steroids and antihistamies pre treatment
name the antimetabolites and general moa
methotrexate fluorouracil pemetrexed cytarabine gemcitabine fludarabine hydroxycarbamide Structurally related to natural compounds. They interefrer with cell metabolism of nuceli acids necessary for DNA, RNA and protein synthesis. Specifically the S phase.
moa and s/e of methotrexate
what is used in addition to MTX for high doses
inhibits folate metabolism thereby inhibiting synethesis of purines and pyramidines required for DNA and RNA synthesis
toxicities: myelosuppression, mucositits, nephrotoxicity
folinic acid given after high dose to promote clearance of MTX and reduce toxicity
moa and s/e of fluorouracil
pro-drug which is activiated within the cell. metabolites act by inhibiting the synthesiis of pyradines. short half life with significant renal and lung clearance
s/e hand and foot syndrome, due to prolonged infusion, diarrhoea, neurotoxicity, myelosuppression, stomatitis, cardiotoxity
can be delivered over 1 weeks via infusion pump
what are the oa and s/e of capectiabine
orally admin pro drug of fluorouracil activated in the tumour itself and in the liver. It can potentially be usd to replace continous infusion of fluourouracil
dose limiting diarrhoea can result in dose reduction or cessation of tretament
can also result in hand and foot syndrome
mos of pemetrexed and how toxicity is reduced
anti-purine whihc acts as an antagonist against enzymes involved in folate dependent pathways whihc results in a decrease of intracellular
toxicity reducd by co-admin of folate supplements and b12
cytarabine moa and s/e
cytosine analogue that competes for cytosine for incorporation into DNA nad RNA
Toxicity: vomiting, myelosuppresion, alopecia
due to rapid clearnace- more effective as continued infusion
moa and s/e of gemcitabine
cytosine analogue. better cell permeation than cytarabine. Toxicities include myelosuppression, oedema, flu-like symptoms, nephrotoxicity
moa and s/e of Fludarabine
adenosine analogue that competes with adenosisne for incorporation into RNA, DNA Before incorporation it is phosphorylated
toxicities include myelosuppression and haemolytic anaemia (abnormal breakdown of rbc)
moa and s/e of hydroxycarbamide
reduced availability of nucleotides by inhibiting ribonucleatide reductase
toxicities: myelosuppression, GI toxicity and hypermigmentation of the skin
moa of platinum complexes and examples
interfere and disrupt teh structure of teh double helix in DNA. they also form cross links whihc are similar to those of alkylating agents
causes electrolyes imbalance especially low magnesium
cisplatin
carboplatin
oxaliplatin
MOA of cisplatin and s/e
bind directly to DNA and forms cross links within strands which Ultimately inhibits DNA synethsis by disrupting the structure
s/e- dose dependenat nephrotoxicity, peripheral neuropathy and ototoxicity. highly emetogenic
initial claerance is fast followed by reduced rate due to plasma binding. renal impairment affects clearncance
what is carboplatin analogue of and what are the s/e
cisplatin analogue - therfore forms cross links with DNA altering strands
tocities- thrombocytopenia , nephotoxicity, ototoxicity, neurotoxicity, alopecia and nausea and vomiting
less toxic than cisplatin other than the thrombocytopenia
clearance dependeant on renal function
moa and s/e of oxaliplatin
Platinum analogue broader spectrum cross links DNA
dose limiting peripheral neuropathy whihc can reverse with withdrawal of oxaliplatin
also diarrhoea, n/v bone marrow suppression and ototoxicity